Research at University Health Network
 
Technology Transfer
Menu Level 3  
   
 
Joseph M Brandwein, FRCPC, MD

Clinical Studies Resource Centre Member
Ontario Cancer Institute (OCI)

Keywords: clinical trials, acute leukemia, myelodysplasia 

Research Interests
My research focuses on evaluating novel agents in the treatment of acute leukemias and related disorders such as myelodysplastic syndromes. I have a number of investigator initiated clinical studies focusing on using small molecule inhibitors and hypomethylating agents to target intracellular pathways mediating chemotherapy drug resistance in acute myeloid leukemia. These include correlative studies to attempt to better understand these mechanisms. I am also involved with a number of international multicentre studies testing novel agents, both alone and in combination, in leukemias.

My research also involves evaluating outcomes with standard treatment regimens in acute myeloid and lymphoblastic leukemia, in order to identify important prognostic factors, as well as protocol development focusing on improving outcomes and treatment related toxicities.

Pubmed Publications
Perform an automatic PubMed search of this researcher's publications.
 
 
 
 
Mailing Address
Primary Office
Princess Margaret Cancer Centre
5th Floor Rm 109
610 University Ave
Toronto, Ontario
Canada M5G 2M9

 
Email

Phone Numbers
416.946.4501 x2824(Primary)
416-946-6546(FAX)

 

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI